Damage to polymer of paclitaxel-eluting stent.
The polymer of paclitaxel-eluting stents (PES) plays an important role in controlling the release of paclitaxel. Damage to the polymer of a PES that is used in a patient has not been demonstrated, although in-vitro studies report disruption of it. The present case report describes damage to a PES as delivery through a calcified coronary artery was being attempted.
Kitahara
Hideki
H
Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chuo-ku, Chiba, Japan.
Kobayashi
Yoshio
Y
Yamaguchi
Masashi
M
Ohkubo
Kenji
K
Nakayama
Takashi
T
Kuroda
Nakabumi
N
Komuro
Issei
I
D000972:Antineoplastic Agents, Phytogenic; D002114:Calcinosis / Q000628:therapy; D023903:Coronary Restenosis / Q000628:therapy; D003331:Coronary Vessels / Q000648:ultrastructure; D054855:Drug-Eluting Stents; D006083:Graft Occlusion, Vascular / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D017239:Paclitaxel
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel